1-[(4-Methylsulfonyl)phenyl]-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole manufacturers
- SC-58125
-
- $35.00
-
2026-07-27
- CAS:162054-19-5
- Purity: 99.81%
- Supply Ability: 10g
|
| | 1-[(4-Methylsulfonyl)phenyl]-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole Basic information |
| Product Name: | 1-[(4-Methylsulfonyl)phenyl]-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole | | Synonyms: | SC-58125;5-(4-Fluorophenyl)-1-[4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)pyrazole;5-(4-Fluoro-phenyl)-1-(4-methanesulfonyl-phenyl)-3-trifluoromethyl-1H-pyrazole;5-(4-Fluorophenyl)-1-[4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole;1H-Pyrazole, 5-(4-fluorophenyl)-1-[4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)-;Cyclooxygenase,cancer,SC58125,COX,Inhibitor,SC-58125,inflammatory,antitumor,COX-2,edema,inhibit;SC-58125, 10 mM in DMSO;SC-58125 ,E0789 | | CAS: | 162054-19-5 | | MF: | C17H12F4N2O2S | | MW: | 384.35 | | EINECS: | | | Product Categories: | | | Mol File: | 162054-19-5.mol | ![1-[(4-Methylsulfonyl)phenyl]-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole Structure](CAS/GIF/162054-19-5.gif) |
| | 1-[(4-Methylsulfonyl)phenyl]-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole Chemical Properties |
| storage temp. | Store at +4°C | | solubility | DMSO: ≥20mg/mL | | form | powder | | color | white to off-white | | InChI | 1S/C17H12F4N2O2S/c1-26(24,25)14-8-6-13(7-9-14)23-15(10-16(22-23)17(19,20)21)11-2-4-12(18)5-3-11/h2-10H,1H3 | | InChIKey | JHBIMJKLBUMNAU-UHFFFAOYSA-N | | SMILES | CS(=O)(=O)c1ccc(cc1)-n2nc(cc2-c3ccc(F)cc3)C(F)(F)F |
| Hazard Codes | T | | Risk Statements | 25 | | Safety Statements | 45-24/25-22 | | WGK Germany | 3 | | Storage Class | 11 - Combustible Solids |
| | 1-[(4-Methylsulfonyl)phenyl]-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole Usage And Synthesis |
| Chemical Properties | White to Off-White Solid | | Uses | SC-58125 is a selective cyclooxygenase 2 (COX-2) inhibitor with anti-inflammatory properties. SC-58125 blocks edema and hyperalgesia without causing gastric mucosal damage. SC-58125 also displays anti
tumor activity. | | Definition | ChEBI: A member of the class of pyrazoles that is 1H-pyrazole substituted by a 4-fluorophenyl group at position 5, a 4-(methylsulfonyl)phenyl group at position 1 and a trifluoromethyl group at position 3. A selective cyclooxygenase 2 inhibitor
it exhibits anticancer property. | | Biological Activity | Selective cyclooxygenase 2 (COX-2) inhibitor (IC 50 values are 0.04 and >100 μ M for COX-2 and COX-1 respectively). Anti-inflammatory; blocks edema and hyperalgesia in vivo following an inflammatory insult, without causing gastric mucosal damage. Also displays antitumor activity. | | in vivo | SC-58125 (10 mg/kg; i.p. every 48 h) inhibits the growth of established colorectal cancer xenografts in mice[3].
SC-58125 (10 mg/kg; a single i.p.) reduces tumor PGE2 levels in mice[3].
SC-58125 (10 mg/kg; a single i.p.) does not change the tumor levels of COX-1 and COX-2 protein in mice[3]. | Animal Model: | Athymic Sprague-Dawley mice are injected HCA-7 cells[3] | | Dosage: | 10 mg/kg | | Administration: | I.p. every 48 h; at the time of tumor implantation or 2 and 4 weeks later | | Result: | Decreased the tumor growth rates significantly. |
| | IC 50 | hCOX-2: 0.04 μM (IC50); hCOX-1: >100 μM (IC50) |
| | 1-[(4-Methylsulfonyl)phenyl]-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole Preparation Products And Raw materials |
|